No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Shell Companies
EvoNext Holdings SA is dedicated to the exploration, creation, and distribution of pioneering ingredients across the nutritional, health, and wellness domains. Founded in 2004, the company's inception is attributed to Alexandra Santana Sørensen, Søren V. S. Nielsen, and Neil Goldsmith. Its corporate headquarters are located in Reinach, Switzerland.
evonextholdings.comNo one on the platform currently holds EVE.SW.
No tracked institution reports a position in EVE.SW as of their last filing.
No one on the platform has traded EVE.SW yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $61M | +86.5% | $2.50 | $2.50–$2.50 | — | 1 |
| 2027 | $78M | +28.4% | $0.00 | $0.00–$0.00 | — | 0 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| EVE.SWEvoNext Holdings S.A. | $2.05 | -8.89% | $15M | — |
| ADXN.SWAddex Therapeutics Ltd | $0.02 | +3.39% | $4M | — |
| BSLN.SWBasilea Pharmaceutica AG | $66.10 | -0.90% | $818M | — |
| MOLN.SWMolecular Partners AG | $3.27 | -1.80% | $123M | — |
| NWRN.SWNewron Pharmaceuticals S.p.A. | $11.06 | -2.47% | $230M | — |
| SANN.SWSanthera Pharmaceuticals Holding AG | $15.56 | -1.27% | $231M |
Source: Financial Modeling Prep · peers by sector/industry
| — |